C. P. M. Ronteltap

Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR

Ralph A. Willemsen, M. E. M. Weijtens, C. P. M. Ronteltap et al. · Gene Therapy · 2000 · 169 citations

Cell Therapy, Cancer Immunosurveillance, Immunology +8

Characterization of natural killer (NK) cells and killer (K) cells in human blood: Discrimination between NK and K cell activities

R. L. H. Bolhuis, H. R. E. Schuit, A. M. Nooyen et al. · European Journal of Immunology · 1978 · 80 citations

Immunohematology, Laboratory Immunology, Lymphocyte Development +23

Rapidly expanded activated human killer cell clones have strong antitumor cell activity and have the surface phenotype of either T gamma, T-non-gamma, or null cells.

R J van de Griend, B.A. Van Krimpen, C. P. M. Ronteltap et al. · The Journal of Immunology · 1984 · 71 citations · Full text

T-regulatory Cell, Null Cells, Immunology +16

T Cell Retargeting with MHC Class I-Restricted Antibodies: The CD28 Costimulatory Domain Enhances Antigen-Specific Cytotoxicity and Cytokine Production

Ralph A. Willemsen, C. P. M. Ronteltap, Patrick Chames et al. · The Journal of Immunology · 2005 · 68 citations · Full text

Lysis of tumor cells by CD3+4-8-16+ T cell receptor <i>alpha</i>  <i>beta</i>- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon <i>beta</i>.

R J van de Griend, W.J.M. Tax, B.A. Van Krimpen et al. · The Journal of Immunology · 1987 · 68 citations